The Hanover Insurance Group, Inc. Form 4 Filings

Bunting Theodore H JR reported acquisition or exercise transactions in this Form 4 filing.

HANOVER INSURANCE GROUP, INC. director Theodore H. Bunting Jr. received an award of 843 shares of common stock on May 12, 2026, recorded at no cash price per share. These are restricted stock units granted under the company’s 2022 Long-Term Incentive Plan and will vest on the earlier of one year from the grant date or the next annual meeting. Following this grant, Bunting directly owns 7,031 shares of common stock.

Bradicich Kevin reported acquisition or exercise transactions in this Form 4 filing.

HANOVER INSURANCE GROUP director Kevin Bradicich received an equity award. He was granted 843 shares of common stock in the form of restricted stock units at a stated price of $0.00 per share under the company’s 2022 Long-Term Incentive Plan.

The units vest on the earlier of one year from the grant date or the next annual meeting. Following this grant, Bradicich holds 10,092 common shares directly, making this a relatively small, routine compensation-related award rather than a market purchase or sale.

Aristeguieta Francisco reported acquisition or exercise transactions in this Form 4 filing.

HANOVER INSURANCE GROUP director Francisco Aristeguieta received a grant of 843 shares of Common Stock as a compensation award. The grant is in the form of restricted stock units under the 2022 Long-Term Incentive Plan and will vest on the earlier of one year from grant or the next annual meeting, bringing his direct holdings to 5,053 shares.

Carlin Jane D reported acquisition or exercise transactions in this Form 4 filing.

HANOVER INSURANCE GROUP, INC. director Jane D. Carlin reported an equity grant in the form of 843 shares of common stock on May 12, 2026. The award was granted at no cash cost to her and is described as restricted stock units under the company’s 2022 Long-Term Incentive Plan.

These units vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting. After this grant, Carlin directly holds 3,266 common shares. A footnote also notes an additional 2,306 shares held indirectly in a Rabbi Trust pursuant to deferral agreements, separate from the reported direct holdings.

HANOVER INSURANCE GROUP, INC. director Cynthia Egan reported receiving an equity award in the form of 843 shares of common stock at $0.00 per share, classified as a grant or award acquisition. This grant was issued as restricted stock units under the company’s 2022 Long-Term Incentive Plan.

The units vest on the earlier of the one-year anniversary of the grant date or the next annual meeting, and Egan has elected to defer the grant upon vesting under a deferral agreement. After this award, she directly owns 10,202 shares of common stock, and a footnote states this does not include 977 shares held indirectly in a Rabbi Trust under deferral agreements.

Hanover Insurance Group Executive Vice President Denise Lowsley sold 1,062 shares of common stock in an open-market transaction. The shares were sold at a price of $188.43 per share. After this sale, she directly holds 3,882.513 Hanover Insurance Group common shares.

Hanover Insurance Group Executive Vice President T. Willard Lee reported an open-market sale of 1,000 shares of Common Stock at $183.93 per share. After this transaction, Lee directly holds 5,982.373 shares. This filing reflects a single sale transaction with no derivative securities reported.

Hanover Insurance Group director Cynthia Egan sold 3,400 shares of Common Stock in an open-market transaction at $188.50 per share. After this sale, she directly holds 9,359 shares. A footnote states she also has 977 shares held indirectly, in addition to her direct holdings.

Lee Willard T reported acquisition or exercise transactions in this Form 4 filing.

Hanover Insurance Group Executive Vice President T. Lee received 13.522 shares of common stock in the form of restricted stock units (RSUs). These RSUs were granted under the company’s 2022 Long-Term Incentive Plan as dividend equivalent rights on previously granted RSUs and will vest on the third anniversary of the original RSU grant date. Following this award, Lee directly holds 6,982.373 shares of common stock.

Hanover Insurance Group Executive Vice President David John Lovely received an additional equity award in the form of dividend-equivalent restricted stock units. He acquired 13.246 shares of Common Stock at a stated price of $0.0000 per share, increasing his directly held position to 3,807.921 shares.

The award represents RSUs granted under Hanover’s 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs. These RSUs will vest on the third anniversary of the original RSU grant date, so this is a compensation-related accrual rather than an open-market stock purchase or sale.

Hanover Insurance Group Executive Vice President Denise Lowsley received an additional equity grant through dividend equivalents on existing awards. She acquired 12.273 shares of common stock in the form of restricted stock units under the 2022 Long-Term Incentive Plan, bringing her direct holdings to 4,944.513 shares.

The new RSUs were granted in connection with accrued dividend equivalent rights tied to previously granted RSUs and will vest on the third anniversary of the original RSU grant date.

Hanover Insurance Group executive Jeffrey M. Farber received a small equity award in the form of restricted stock units. He acquired 53.2520 shares of common stock-equivalent RSUs on March 27, 2026 as a grant under the company’s 2022 Long-Term Incentive Plan tied to dividend equivalents.

These RSUs vest on the third anniversary of the original underlying RSU grant date, meaning they are subject to continued service-based vesting. Following this grant, Farber directly holds 51,769.7370 shares of Hanover Insurance Group common stock, reflecting ongoing equity-based compensation rather than an open-market transaction.

HANOVER INSURANCE GROUP, INC. Executive Vice President Dennis Francis Kerrigan reported an acquisition of 18.998 shares in the form of restricted stock units (RSUs) credited as dividend equivalent rights under the company’s 2022 Long-Term Incentive Plan. These RSUs will vest on the third anniversary of the original underlying RSU grant date. Following this award, Kerrigan holds a total of 11,987.721 shares of common stock directly.

LAVEY RICHARD W reported acquisition or exercise transactions in this Form 4 filing.

HANOVER INSURANCE GROUP, INC. Executive Vice President Richard W. Lavey received a grant of 35.468 restricted stock units (RSUs) tied to dividend equivalent rights under the company’s 2022 Long-Term Incentive Plan. These RSUs will vest on the third anniversary of the original underlying RSU grant, and following this award he holds 34,418.208 shares of common stock directly.

Roche John C reported acquisition or exercise transactions in this Form 4 filing.

Hanover Insurance Group President and CEO John C. Roche received 152.574 shares of common stock through restricted stock units granted under the company’s 2022 Long-Term Incentive Plan. These RSUs were issued as dividend equivalent rights tied to previously granted RSUs and will vest on the third anniversary of the original RSU grant date.

After this award, Roche directly holds 141,010.748 shares of Hanover common stock, and the filing notes an additional 14,454 shares held by his spouse. This transaction reflects routine equity-based compensation rather than an open-market purchase.

Salvatore Bryan J reported acquisition or exercise transactions in this Form 4 filing.

HANOVER INSURANCE GROUP, INC. Executive Vice President Salvatore J. Bryan received a grant of 30.677 restricted stock units as a dividend-related award in common stock. The units were granted under the company’s 2022 Long-Term Incentive Plan and tie to dividend equivalent rights on previously granted RSUs. These RSUs will vest on the third anniversary of the original underlying RSU grant date. Following this award, Bryan’s direct holdings total 29,069.276 shares of common stock.

Hanover Insurance Group director Jane D. Carlin reported an open-market sale of common stock. On February 27, 2026, she sold 1,200 shares at a weighted average price of $180.91 per share, with individual sale prices ranging from $180.79 to $181.02.

After this transaction, she directly owns 2,423 Hanover common shares. A footnote also notes an additional 2,306 shares held indirectly in a Rabbi Trust pursuant to deferral agreements, which are not included in the reported direct holdings.

Hanover Insurance Group Executive Vice President Dennis Francis Kerrigan reported a tax-related share disposition connected to vesting equity awards. On the vesting of previously granted restricted stock units, 1,751 shares of common stock were forfeited at $180.63 per share to cover withholding taxes, a non‑market transaction. After this withholding, Kerrigan directly holds about 11,968.723 Hanover common shares.

Hanover Insurance Group executive Jeffrey M. Farber reported a tax-related share disposition. On February 27, 2026, 5,507 shares of common stock were forfeited at $180.63 per share to cover withholding taxes triggered by the vesting of previously granted restricted stock units.

After this tax-withholding disposition, Farber directly holds 51,716.485 shares of Hanover Insurance Group common stock. The forfeited shares were not an open-market sale but an automatic share surrender under the terms of the equity award agreement.

HANOVER INSURANCE GROUP, INC. Executive Vice President Richard W. Lavey reported an administrative share disposition tied to equity compensation. On February 27, 2026, 3,220 shares of common stock at $180.63 per share were forfeited to cover withholding taxes upon the vesting of previously granted restricted stock units. After this tax-withholding disposition, he directly owned 34,382.74 common shares.

Hanover Insurance Group Executive Vice President Salvatore J. Bryan reported a Form 4 transaction involving 2,807 shares of common stock on February 27, 2026. These shares were forfeited to cover withholding taxes upon the vesting of previously granted restricted stock units at $180.63 per share. After this tax-withholding disposition, Bryan directly owned 29,038.599 shares of Hanover common stock.

Hanover Insurance Group President and CEO John C. Roche reported a tax-related share disposition connected to equity compensation. On February 27, 2026, 14,220 shares of common stock were forfeited to cover withholding taxes upon the vesting of previously granted restricted stock units at an indicated price of $180.63 per share. After this tax-withholding disposition, he directly held 140,858.174 common shares, while an additional 14,454 shares are held by his spouse and are not included in his reported direct holdings.

Hanover Insurance Group executive vice president David John Lovely reported a tax-related share disposition. On February 27, he forfeited 1,068 shares of common stock at $180.63 per share to cover withholding taxes triggered by vesting of previously granted restricted stock units. After this withholding, he holds 3,794.675 shares of common stock directly.

Hanover Insurance Group executive Denise Lowsley disposed of 1,207 shares of common stock to cover taxes on vested restricted stock units. The shares were forfeited at $180.63 per share on February 27, 2026, and she now directly holds 4,932.24 shares.

Hanover Insurance Group executive vice president Lee Willard T reported a tax-related share disposition. On February 27, 2026, 1,215 shares of common stock were forfeited at $180.63 per share to cover withholding taxes upon vesting of previously granted restricted stock units. After this tax-withholding disposition, he directly owns 6,968.851 common shares.

Hanover Insurance Group executive Jeffrey M. Farber reported multiple equity awards tied to the company’s long-term incentive plan. On February 24, 2026, he acquired 14,436 stock options at an exercise price of $0.0000 per share.

He also acquired 5,043, 3,250 and 3,025 shares of common stock through performance-based and time-based restricted stock units granted under the 2022 Long-Term Incentive Plan. Certain performance-based awards had their performance conditions certified and are scheduled to vest on February 27, 2026.

Hanover Insurance Group Executive Vice President Dennis Francis Kerrigan reported equity awards under the company’s long-term incentive plans. On February 24, 2026, he acquired 5,328 stock options with an exercise price of $0.0000 per share and 1,730 shares of common stock at no cost.

He also received additional common stock awards of 1,115 shares and 1,117 shares, each reported as grants or other acquisitions, bringing his direct common stock holdings to 13,719.585 shares. Footnotes indicate that related performance-based and restricted stock unit awards vest over multi‑year periods, with some vesting on February 27, 2026, and options vesting in thirds on each of the first three anniversaries of grant.

Hanover Insurance Group Executive Vice President Richard W. Lavey reported multiple equity awards tied to the company’s 2022 Long-Term Incentive Plan. On February 24, 2026, he acquired 9,968 stock options at an exercise price of $0.00 per share and several stock-based awards totaling 6,828 common shares at no cost.

The stock awards reflect performance-based restricted stock units whose performance conditions were certified at 150% and 100% of target, plus a time-based restricted stock unit grant. The performance-based awards are scheduled to vest on February 27, 2026, while other units and options vest over a three-year period.

HANOVER INSURANCE GROUP, INC. Executive Vice President David John Lovely reported equity awards rather than open‑market trades. On February 24, 2026, he acquired a stock option for 3,781 shares at a grant price of $0.00 per share and several stock grants also at no cost.

The filing shows three separate common stock awards of 1,082, 698, and 793 shares, all recorded as grants or awards. Footnotes explain these awards relate to performance‑based and time‑based restricted stock units under the company’s 2022 Long‑Term Incentive Plan, with vesting tied to February 27, 2026 or later anniversaries.

Hanover Insurance Group Executive Vice President Denise Lowsley reported equity awards and vesting-related share grants. On February 24, 2026, she was granted a stock option for 3,094 shares of common stock, which vests in three equal annual installments from the grant date.

She also acquired 1,154 restricted stock units that vest on the third anniversary of grant. In addition, performance-based restricted stock unit awards granted in 2023 had their performance conditions certified, resulting in 744 shares tied to a 150% performance outcome and 649 shares tied to a 100% performance outcome, both still subject to time-based vesting through February 27, 2026.

Roche John C reported acquisition or exercise transactions in this Form 4 filing.

HANOVER INSURANCE GROUP, INC. President and CEO John C. Roche reported equity awards tied to the company’s long-term incentive plan. He received an option to buy 45,025 shares of common stock, plus stock-based awards totaling 31,229 shares at no cash cost to him.

Footnotes explain that these grants reflect performance-based restricted stock units from a 2023 award, with performance certified at 150% and 100% of target and vesting on February 27, 2026, as well as new restricted stock units and options that generally vest over three years.

Hanover Insurance Group Executive Vice President Salvatore Bryan J reported equity awards and vesting-related acquisitions of company stock and options. On February 24, 2026, he received a grant of 8,937 common stock options at a price of $0 per share.

He also acquired common shares through performance-based restricted stock units and restricted stock units. These include awards of 2,595, 1,672, and 1,873 common shares, all at $0 per share. Two PBRSU awards granted in 2023 had their performance conditions certified at 150% and 100% of target and remain subject to time-based vesting until February 27, 2026. A separate RSU grant vests on the third anniversary of grant, and the options vest in three equal annual installments.

Hanover Insurance Group Executive Vice President T. Willard Lee reported equity awards under the company’s 2022 Long-Term Incentive Plan. On February 24, 2026, he acquired 3,781 stock options with an exercise right described as a common stock option. These options vest in three equal annual installments on each of the first three anniversaries of the grant date.

On the same date, he also acquired a total of 2,691 shares or units of common stock at no cost in multiple grants. Footnotes explain that earlier performance-based restricted stock units granted on February 27, 2023 had performance conditions certified at 150% and 100% of target, with all such awards remaining subject to time-based vesting and scheduled to vest on February 27, 2026, while another restricted stock unit grant vests on its third anniversary.

Hanover Insurance Group Executive Vice President Richard W. Lavey reported multiple equity transactions in company common stock. On February 5, 2026, he exercised a stock option for 17,420 shares at an exercise price of $77.91 per share and received common stock.

That same day, he sold several blocks of Hanover common stock at weighted average prices between $178.05 and $179.83, as detailed in the price ranges provided in the notes. He also made a charitable gift of 1,400 shares. Following all reported transactions, he directly owned 30,773.879 Hanover common shares.

The Hanover Insurance Group director Jane D. Carlin reported an internal share transfer rather than a new purchase or sale. On January 23, 2026, a total of 3,623 shares of Hanover common stock previously held indirectly under a deferral agreement were reclassified to direct ownership at a stated price of $0. The footnote explains this was a change of ownership from indirect to direct pursuant to the terms of a deferral agreement for stock previously awarded under the company’s 2014 Long-Term Incentive Plan. Following the transaction, Carlin held 3,623 shares directly and 2,306 shares indirectly under the deferral arrangement.

Hanover Insurance Group, Inc. reported that an executive vice president acquired additional common stock through a grant of restricted stock units. On 12/26/2025, the officer received 26.937 shares of common stock at a price of $0, recorded as an acquisition. After this transaction, the officer beneficially owned 25,704.879 shares of common stock in direct ownership. The new RSUs were granted under the company’s 2022 Long-Term Incentive Plan as dividend equivalent rights tied to previously granted RSUs and will vest on the third anniversary of the grant date of the original RSUs.

Hanover Insurance Group, Inc. reported an insider equity grant for its President and CEO, who also serves as a director. On 12/26/2025, the executive acquired 134.535 shares of common stock at a price of $0 through restricted stock units under the company’s 2022 Long-Term Incentive Plan. These units were issued as dividend equivalent rights tied to previously granted RSUs and will vest on the third anniversary of the original RSU grant date.

Following this transaction, the executive beneficially owns 123,849.174 shares directly. The filing notes that this total does not include 14,454 shares held by the executive’s spouse.

Hanover Insurance Group, Inc. reported a routine equity award transaction for an executive officer. On 12/26/2025, the officer, who serves as Executive Vice President, received 11.844 shares of common stock in the form of restricted stock units (RSUs) at a price of $0 under the company’s 2022 Long-Term Incentive Plan.

The RSUs were granted as dividend equivalent rights tied to RSUs previously awarded under the same plan. These additional RSUs will vest on the third anniversary of the grant date of the original underlying RSUs. Following this transaction, the officer beneficially owns 3,523.34 shares of Hanover common stock in direct form.

Hanover Insurance Group executive reports small RSU grant

A Hanover Insurance Group, Inc. Executive Vice President reported receiving a grant of 11.747 shares of common stock in the form of restricted stock units (RSUs) on 12/26/2025. These RSUs were credited as dividend equivalent rights tied to RSUs previously granted under the company’s 2022 Long-Term Incentive Plan and will vest on the third anniversary of the original underlying RSU grant date. Following this transaction, the executive beneficially owns 2,289.372 shares of Hanover Insurance Group common stock directly. The RSUs were reported at a price of $0, consistent with a stock-based compensation award rather than an open-market purchase.

Hanover Insurance Group, Inc. reported that an Executive Vice President received additional common stock through a restricted stock unit (RSU) dividend accrual. On 12/26/2025, the officer acquired 12.247 shares of common stock at a price of $0, increasing direct beneficial ownership to 5,491.951 shares.

The new RSUs were granted under the company’s 2022 Long-Term Incentive Plan as dividend equivalent rights tied to previously granted RSUs. These RSUs will vest on the third anniversary of the grant date of the original underlying RSUs, aligning the executive’s compensation with long‑term shareholder interests.

Hanover Insurance Group, Inc. reported an equity award for an executive vice president through a Form 4 filing. On 12/26/2025, the officer acquired 31.585 shares of common stock at a price of $0, increasing their direct beneficial ownership to 39,173.879 shares. The transaction is coded as an acquisition related to the company’s long-term incentive program.

According to the explanation, this represents a grant of restricted stock units (RSUs) under the 2022 Long-Term Incentive Plan tied to dividend equivalent rights on previously granted RSUs. These RSUs will vest on the third anniversary of the grant date of the original underlying RSUs, meaning the added units follow the same vesting schedule as the original award.

Hanover Insurance Group, Inc. reported that an executive vice president received a small additional equity grant through its long-term incentive program. On 12/26/2025, the officer acquired 17.312 shares of common stock at a price of $0, increasing their direct beneficial ownership to 9,757.585 shares.

The new shares were granted as restricted stock units (RSUs) under Hanover’s 2022 Long-Term Incentive Plan. They arose from dividend equivalent rights tied to RSUs previously granted under the same plan, meaning the executive receives added RSUs in lieu of cash dividends on earlier awards. These RSUs will vest on the third anniversary of the original RSU grant date, aligning the executive’s interests with longer-term company performance.

Hanover Insurance Group, Inc. reported an equity award transaction for an executive vice president on a Form 4. On 12/26/2025, the officer acquired 49.71 shares of common stock in the form of restricted stock units (RSUs) at a price of $0 per share, increasing their beneficial ownership to 45,905.205 shares held directly.

The RSUs were granted under the company’s 2022 Long-Term Incentive Plan in connection with dividend equivalent rights that accrued on previously granted RSUs. These RSUs vest on the third anniversary of the date of grant of the original underlying RSUs, meaning the officer will receive the underlying shares only if the vesting conditions tied to the original grant are satisfied.

Hanover Insurance Group, Inc. executive reports routine tax withholding transaction. An Executive Vice President of Hanover Insurance Group, Inc. (THG) reported the disposition of 150 shares of common stock on 12/01/2025 at a price of $185.91 per share. According to the footnote, these shares were withheld from restricted stock unit awards to cover FICA and related income tax obligations for an executive eligible for retirement vesting under the award terms. Following this transaction, the reporting person beneficially owns 9,740.273 shares of Hanover common stock, held directly. The filing is a standard Form 4 for one reporting person and does not describe any derivative securities activity.

Hanover Insurance Group executive reports routine tax withholding of shares. An executive vice president of Hanover Insurance Group, Inc. reported a disposition of 242 shares of common stock on 12/01/2025 coded as an "F" transaction, meaning shares were withheld to cover tax obligations. The shares were valued at $185.91 each and were taken from restricted stock unit awards to satisfy FICA and related income taxes for an executive eligible for retirement vesting under the award terms.

Following this withholding, the executive directly beneficially owned 25,677.942 shares of Hanover Insurance Group common stock.

Hanover Insurance Group, Inc. President and CEO, who is also a director, reported an automatic share withholding related to equity compensation. On 12/01/2025, 382 shares of common stock were withheld at a price of $185.91 per share to cover FICA and related income tax obligations tied to restricted stock unit awards for an executive eligible for retirement vesting.

Following this tax withholding, the reporting person directly beneficially owns 123,714.639 shares of Hanover common stock. This figure does not include an additional 14,454 shares held by the reporting person’s spouse.

Hanover Insurance Group (THG) reported an insider transaction by its Executive Vice President. On 11/12/2025, the officer recorded a sale of 1,619 shares of common stock at a price of $181.47 per share (Transaction Code: S). Following the trade, the reporting person’s direct beneficial ownership was 3,511.496 shares. No derivative securities were reported in Table II.

Hanover Insurance Group (THG) reported an insider Form 4 for its President and CEO, who is also a Director, detailing a charitable gift of 590 shares of common stock on 11/05/2025 at $0 (transaction code G).

Following the transaction, the reporting person directly beneficially owns 124,096.639 shares. A note states this total does not include 14,454 shares held by the reporting person’s spouse.

Hanover Insurance Group (THG) Executive Vice President reported a charitable gift of 175 shares on 11/04/2025 on Form 4. The transaction was coded G (gift) at a price of $0. After this transaction, the reporting person directly owned 9,890.273 shares of common stock.